Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVARREST vs TachoSil in Aortic Reconstruction
NCT02040428Phase 3Completed
- Sponsor
- Ethicon
- Start
- Jan 2014
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 5
01
Overview
A Phase 3 trial of Fibrin Pad, sponsored by Ethicon. Started Jan 2014; status: completed.
02
Drugs
Fibrin Pad
Beyond the preview
Go deeper on NCT02040428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040428.